Nevertheless, AMH treatment was shown not to interfere with the cytotoxic actions of cyclophosphamide on breast cancer cells or an in vivo model of human leukaemia (Roness et al., 2019) and AMH has been shown not to affect tumour growth (Kano et al., 2017). This evidence concerns the gene AMH and breast carcinoma.